These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 17085207)

  • 1. Re: Cystectomy delay more than 3 months from initial bladder cancer diagnosis results in decreased disease specific and overall survival. C. T. Lee, R. Madii, S. Daignault, R. L. Dunn, Y. Zhang, J. E. Montie and D. P. Wood, Jr., J Urol, 175: 1262-1267, 2006.
    Horan AH
    J Urol; 2006 Dec; 176(6 Pt 1):2744. PubMed ID: 17085207
    [No Abstract]   [Full Text] [Related]  

  • 2. Re: preoperative hydronephrosis predicts extravesical and node positive disease in patients undergoing cystectomy for bladder cancer. C. J. Stimson, M. S. Cookson, D. A. Barocas, P. E. Clark, J. E. Humphrey, S. G. Patel, J. A. Smith, Jr. and S. S. Chang. J Urol 2010; 183: 1732-1737.
    Neulander EZ; Katz T; Yusim I; Kaneti J
    J Urol; 2011 Apr; 185(4):1536-7. PubMed ID: 21334665
    [No Abstract]   [Full Text] [Related]  

  • 3. Re: Patterns of recurrence and outcomes following induction bacillus Calmette-Guerin for high risk Ta, T1 bladder cancer s. P. Lerner, C. M. Tangen, H. Sucharew, D. Wood and E. D. Crawford J Urol 2007; 177: 1727-1731.
    Lamm DL
    J Urol; 2008 Feb; 179(2):788. PubMed ID: 18082825
    [No Abstract]   [Full Text] [Related]  

  • 4. Re: Transurethral partial cystectomy with continuous wave laser for bladder carcinoma. Y. Yang, Z.-t. Wei, X. Zhang, B.-F. Hong and G. Guo. J Urol 2009; 182: 66-69.
    Neulander EZ; Katz T; Klein J; Kaneti J
    J Urol; 2010 Mar; 183(3):1257. PubMed ID: 20096882
    [No Abstract]   [Full Text] [Related]  

  • 5. A delay in radical cystectomy of >3 months is not associated with a worse clinical outcome.
    Nielsen ME; Palapattu GS; Karakiewicz PI; Lotan Y; Bastian PJ; Lerner SP; Sagalowsky AI; Schoenberg MP; Shariat SF
    BJU Int; 2007 Nov; 100(5):1015-20. PubMed ID: 17784888
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A delay in radical cystectomy of >3 months is not associated with a worse clinical outcome.
    Ayres BE; Gillatt D; McPhail S; Cottrell A; McGrath J; Cottier B; Verne J; Persad RA;
    BJU Int; 2008 Sep; 102(8):1045. PubMed ID: 18840144
    [No Abstract]   [Full Text] [Related]  

  • 7. Re: Matthew E. Nielsen, Shahrokh F. Shariat, Pierre I. Karakiewicz et al. Advanced age is associated with poorer bladder cancer-specific survival in patients treated with radical cystectomy. Eur urol 2007;51:699-708.
    Cai T; Bartoletti R
    Eur Urol; 2007 Aug; 52(2):611-2. PubMed ID: 17400362
    [No Abstract]   [Full Text] [Related]  

  • 8. Re: Potency preserving cystectomy with intrafascial prostatectomy for high risk superficial bladder cancer: P. Puppo, C. Introini, F. Bertolotto and A. Naselli J Urol 2008; 179: 1727-1732.
    Mandhani A
    J Urol; 2008 Dec; 180(6):2713; author reply 2173-4. PubMed ID: 18951579
    [No Abstract]   [Full Text] [Related]  

  • 9. Longer wait times increase overall mortality in patients with bladder cancer.
    Kulkarni GS; Urbach DR; Austin PC; Fleshner NE; Laupacis A
    J Urol; 2009 Oct; 182(4):1318-24. PubMed ID: 19683272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Re: can restaging transurethral resection of T1 bladder cancer select patients for immediate cystectomy? H. W. Herr, S. M. Donat and G. Dalbagni J Urol 2007; 177: 75-79.
    Nieder AM; Soloway MS; Jewett MA
    J Urol; 2007 Jul; 178(1):352. PubMed ID: 17507038
    [No Abstract]   [Full Text] [Related]  

  • 11. Positive surgical margins in soft tissue following radical cystectomy for bladder cancer and cancer specific survival.
    Dotan ZA; Kavanagh K; Yossepowitch O; Kaag M; Olgac S; Donat M; Herr HW
    J Urol; 2007 Dec; 178(6):2308-12; discussion 2313. PubMed ID: 17936804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Bladder preservation or initial cystectomy in T1G3 bladder cancer: which parameters help in therapeutic decision-making?].
    Denzinger S; Burger M; Fritsche HM; Ganzer R; Blana A; Wieland WF; Otto W
    Aktuelle Urol; 2008 Jan; 39(1):58-61; discussion 62-3. PubMed ID: 18228189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early versus deferred cystectomy for initial high-risk pT1G3 urothelial carcinoma of the bladder: do risk factors define feasibility of bladder-sparing approach?
    Denzinger S; Fritsche HM; Otto W; Blana A; Wieland WF; Burger M
    Eur Urol; 2008 Jan; 53(1):146-52. PubMed ID: 17624657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical outcome of radical cystectomy for patients with pT4 bladder cancer.
    Furukawa J; Miyake H; Hara I; Takenaka A; Fujisawa M
    Int J Urol; 2008 Jan; 15(1):58-61. PubMed ID: 18184174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lymph node density is superior to TNM nodal status in predicting disease-specific survival after radical cystectomy for bladder cancer: analysis of pooled data from MDACC and MSKCC.
    Kassouf W; Agarwal PK; Herr HW; Munsell MF; Spiess PE; Brown GA; Pisters L; Grossman HB; Dinney CP; Kamat AM
    J Clin Oncol; 2008 Jan; 26(1):121-6. PubMed ID: 18165646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nomograms provide improved accuracy for predicting survival after radical cystectomy.
    Shariat SF; Karakiewicz PI; Palapattu GS; Amiel GE; Lotan Y; Rogers CG; Vazina A; Bastian PJ; Gupta A; Sagalowsky AI; Schoenberg M; Lerner SP
    Clin Cancer Res; 2006 Nov; 12(22):6663-76. PubMed ID: 17121885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Re: Serum tumor markers may predict overall and disease specific survival in patients with clinically organ confined invasive bladder cancer. D. Margel, R. Tal and J. Baniel. J Urol 2007; 178: 2297-2301.
    Suzuki K
    J Urol; 2008 Jun; 179(6):2481; author reply 2481. PubMed ID: 18436255
    [No Abstract]   [Full Text] [Related]  

  • 18. Prognostic significance of hydronephrosis in bladder cancer treated by radical cystectomy.
    Resorlu B; Baltaci S; Resorlu M; Ergun G; Abdulmajeed M; Haliloglu AH; Gogus C; Beduk Y
    Urol Int; 2009; 83(3):285-8. PubMed ID: 19829026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The significance of lymphovascular invasion in transurethral resection of bladder tumour and cystectomy specimens on the survival of patients with urothelial bladder cancer.
    Streeper NM; Simons CM; Konety BR; Muirhead DM; Williams RD; O'Donnell MA; Joudi FN
    BJU Int; 2009 Feb; 103(4):475-9. PubMed ID: 18990174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [New markers for pharmacological targeting in bladder cancer with lymph node metastasis].
    Herrmann E; Eltze E; Köpke T; Bolenz C; Bierer S; Neumann J; Hertle L; Wülfing C
    Aktuelle Urol; 2007 Sep; 38(5):392-7. PubMed ID: 17907066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.